News & Perspective

Apr 16, 2019

Apr 16, 2019

News Scan for Apr 16, 2019

Needle-free flu vaccine boost
Promise for chikungunya vaccine
Global flu mostly dropping

Feb 19, 2018

Feb 19, 2018
Drawing vaccine from a vial

Senate bill would jump-start universal flu vaccine efforts

The proposed law would direct $200 million a year for 5 years to research.

Mar 10, 2015

Mar 10, 2015

Flu Scan for Mar 10, 2015

More queries on flu vaccine mismatch
Global flu activity

May 02, 2014

May 02, 2014

News Scan for May 02, 2014

More MERS-CoV antibodies
Ebola in Guinea
Renamed biodefense board
Universal flu vaccine

Dec 17, 2009

Dec 17, 2009

Vaccine availability opens up as doses approach 100 million

(CIDRAP News) – The nation is reaching a new milestone in its fight against pandemic flu, with the number of vaccine doses expected to reach 100 million by the end of the week and nearly half of states opening up immunization to anyone who wants it, federal officials said today.

Nov 24, 2009

Nov 24, 2009

Novartis unveils US cell-based flu vaccine plant

(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.

Nov 04, 2009

Nov 04, 2009

CDC says vaccine shortage likely to outlast current H1N1 wave

(CIDRAP News) – The head of the Centers for Disease Control and Prevention (CDC) predicted today that the current wave of H1N1 influenza is likely to begin to wane before the shortage of vaccine for it eases.

Dr. Thomas Frieden made the comment at a wide-ranging US House subcommittee session that aired the reasons for and impact of the vaccine delays and the prospects for avoiding a repeat of the problem. The session was streamed over the Web.

Aug 21, 2009

Aug 21, 2009

First H1N1 vaccine trial data expected in mid-September

(CIDRAP News) – Federal health officials today said the first results of novel H1N1 vaccine trials—needed for determining the number and size of doses people will get—are expected in mid-September.

Two trials in adult and elderly volunteers started Aug 7 and are now almost fully enrolled, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), at a press teleconference.

Jul 30, 2009

Jul 30, 2009

Packaging, not yield, may be problem for nasal-spray H1N1 vaccine

(CIDRAP News) – While most vaccine manufacturers have reaped below-average crops of H1N1 influenza vaccine virus from the eggs in which they're grown, MedImmune Inc. has a different problem: high virus yields, but a potential shortage of the devices used to spray the vaccine into the nose.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»